These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2751746)

  • 1. Apolipoproteins C-II and C-III metabolism in hypertriglyceridemic patients. Effect of a drastic triglyceride reduction by combined diet restriction and fenofibrate administration.
    Malmendier CL; Lontie JF; Delcroix C; Dubois DY; Magot T; De Roy L
    Atherosclerosis; 1989 Jun; 77(2-3):139-49. PubMed ID: 2751746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fenofibrate on lipids, lipoproteins, and apolipoproteins in 33 subjects with primary hypercholesterolemia.
    Mellies MJ; Stein EA; Khoury P; Lamkin G; Glueck CJ
    Atherosclerosis; 1987 Jan; 63(1):57-64. PubMed ID: 3548734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of fenofibrate on high and low density lipoprotein metabolism in heterozygous familial hypercholesterolemia.
    Malmendier CL; Delcroix C
    Atherosclerosis; 1985 May; 55(2):161-9. PubMed ID: 3924068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of fenofibrate treatment on plasma lipoprotein lipids, high-density lipoprotein cholesterol subfractions, and apolipoproteins B, AI, AII, and E.
    Knopp RH; Walden CE; Warnick GR; Albers JJ; Ginsberg J; McGinnis BM
    Am J Med; 1987 Nov; 83(5B):75-84. PubMed ID: 3120587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoprotein C-III deficiency markedly stimulates triglyceride secretion in vivo: comparison with apoprotein E.
    Hirano T; Takahashi T; Saito S; Tajima H; Ebara T; Adachi M
    Am J Physiol Endocrinol Metab; 2001 Oct; 281(4):E665-9. PubMed ID: 11551841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of fenofibrate and atorvastatin on in vivo kinetics of apolipoproteins B-100 and B-48 in subjects with type 2 diabetes mellitus with marked hypertriglyceridemia.
    Hogue JC; Lamarche B; Deshaies Y; Tremblay AJ; Bergeron J; Gagné C; Couture P
    Metabolism; 2008 Feb; 57(2):246-54. PubMed ID: 18191056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein composition changes induced by fenofibrate in dysbetalipoproteinemia type III.
    Lussier-Cacan S; Bard JM; Boulet L; Nestruck AC; Grothé AM; Fruchart JC; Davignon J
    Atherosclerosis; 1989 Aug; 78(2-3):167-82. PubMed ID: 2783201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of action of gemfibrozil on lipoprotein metabolism.
    Saku K; Gartside PS; Hynd BA; Kashyap ML
    J Clin Invest; 1985 May; 75(5):1702-12. PubMed ID: 3923042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of apolipoprotein C-III in normolipemic human subjects.
    Malmendier CL; Lontie JF; Grutman GA; Delcroix C
    Atherosclerosis; 1988 Jan; 69(1):51-9. PubMed ID: 3355607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein and lipoprotein concentrations in familial apolipoprotein C-II deficiency.
    Breckenridge WC; Alaupovic P; Cox DW; Little JA
    Atherosclerosis; 1982 Aug; 44(2):223-35. PubMed ID: 7138621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible increase of the apo CII/apo CIII-1 ratio in the very low density lipoproteins after procetofen treatment in hypertriglyceridemic patients.
    Franceschini G; Sirtori M; Gianfranceschi G; Frosi T; Montanari G; Sirtori CR
    Artery; 1985; 12(6):363-81. PubMed ID: 4051756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics.
    Chan DC; Watts GF; Nguyen MN; Barrett PH
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):590-6. PubMed ID: 16410456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diet and hypertriglyceridemia: influence of dietary modifications on plasma lipids, lipoproteins and apoproteins in patients with primary hypertriglyceridemia].
    Soriguer Escofet FJ; Escolar Castellón JL; Esteva de Antonio I; Valdivieso Felices P; González Santos P; García Arnes J; Tinahones Madueño F
    Med Clin (Barc); 1992 May; 98(17):646-50. PubMed ID: 1598008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fenofibrate affects the compositions of lipoproteins.
    Goldberg AC; Schonfeld G; Anderson C; Dillingham MA
    Am J Med; 1987 Nov; 83(5B):60-5. PubMed ID: 3318455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.
    Milosavljevic D; Griglio S; Le Naour G; Chapman MJ
    Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoprotein c-III and E-containing lipoparticles are markedly increased in HIV-infected patients treated with protease inhibitors: association with the development of lipodystrophy.
    Bonnet E; Ruidavets JB; Tuech J; Ferrières J; Collet X; Fauvel J; Massip P; Perret B
    J Clin Endocrinol Metab; 2001 Jan; 86(1):296-302. PubMed ID: 11232015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein C-II modifications associated with an infusion of artificial lipid particles.
    Iriyama K; Nishiwaki H; Terashima H; Tonouchi H; Miki C; Suzuki H; Carpentier YA
    JPEN J Parenter Enteral Nutr; 1988; 12(1):60-2. PubMed ID: 3125357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfer of apolipoproteins between plasma lipoproteins and exogenous lipid particles after repeated bolus injections or during a continuous infusion of fat emulsion.
    Tonouchi H; Iriyama K; Carpentier YA
    JPEN J Parenter Enteral Nutr; 1990; 14(4):381-5. PubMed ID: 2119445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of fenofibrate on apolipoprotein kinetics in patients with coexisting dysbetalipoproteinemia and heterozygous familial hypercholesterolemia.
    Tremblay AJ; Lamarche B; Ruel IL; Hogue JC; Deshaies Y; Gagné C; Couture P
    Atherosclerosis; 2006 Sep; 188(1):203-12. PubMed ID: 16337207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of combined fenofibrate and cholestyramine therapy on low-density lipoprotein kinetics in familial hypercholesterolemia patients.
    Malmendier CL; Delcroix C; Lontie JF
    Clin Chim Acta; 1987 Jan; 162(2):221-7. PubMed ID: 3829426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.